DarioHealth Corp.

For the period ended Mar 31, 2025. Filed May 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

DRIO$2.39+16.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)


· · Three months ended
· · March 31,
	2025		2024
Revenues:
Services		$4,875		$4,160
Consumer hardware		1,877		1,598
Total revenues		6,752		5,758

Cost of revenues:
Services		865		965
Consumer hardware		1,130		1,198
Amortization of acquired intangible assets		875		1,163
Total cost of revenues		2,870		3,326

Gross profit		3,882		2,432

Operating expenses:
Research and development		$4,108		$6,642
Sales and marketing		5,873		6,910
General and administrative		3,310		6,735

Total operating expenses		13,291		20,287

Operating loss		9,409		17,855

Total financial income, net		(204)		(8,686)

Loss before taxes		9,205		9,169

Income tax (benefit)		22		(1,994)

Net loss		$9,227		$7,175

Deemed dividend		$4,839		$2,034

Net loss attributable to common shareholders		$14,066		$9,209

Net loss per share:

Basic and diluted loss per share of common stock		$0.14		$0.20
Weighted average number of common stock used in computing basic and diluted net loss per share		47,370,317		34,442,578

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.